Intensive glucose control and cardiovascular disease in type 2 diabetes – should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials
Keyword(s):
2008 ◽
Vol 359
(14)
◽
pp. 1519-1521
◽
Keyword(s):
2007 ◽
Vol 28
(1)
◽
pp. 6-17
◽